Status:
COMPLETED
The Effect of Direct Cyclophotocoagulation Using Endolaser in Silicon Induced Glaucoma: a Pilot Study.
Lead Sponsor:
Kafrelsheikh University
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transcleral cyclophotocoagulation has been used to treat glaucoma secondary to silicone oil
Eligibility Criteria
Inclusion
- . Patients above 18 years of age. .Silicon filled for more than 2 months. .IOP more than 21 mmHg on triple topical antiglaucoma eye drops.
Exclusion
- . History of glaucoma prior to the initial retinal surgery. . Immediate rise of IOP after SOI. . History of previous laser application to the ciliary body. . Any contraindications for silicone oil removal.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05231252
Start Date
June 1 2021
End Date
January 1 2022
Last Update
November 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11771